Syllabus:

Practical exercises:

  • Experiment to demonstrate sympathomimmetic effects etc. qualitatively in experimental animals.
  • Experiment to demonstrate certain actions in experimental animals which are characteristic of antipsychotic compounds.
  • Experiment to identify the unknown drug based on the blood pressure recording of anaesthetized animal.
  • Analysis of the data.
  • Discussion of the given scientific paper.
  • Critical views of the given prescription.
  • Presentation of the dissertation work.
  • Demonstration of the concept of competitive antagonism by using appropriate tissue and drugs.
  • Estimating the potency of ACH solution by using appropriate biological tissue.
  • Presenting a short lecture on the given topic.
  • Preparing a protocol for the clinical trial of the new drug.

Theory:

  • PHARMACOKINETICS AND PHARMACODYNAMICS: THE DYNAMICS OF DRUG ABSORPTION, DISTRIBUTION, ACTION, AND ELIMINATION MEMBRANE TRANSPORTERS AND DRUG RESPONSE DRUG METABOLISM PHARMACOGENETICS
  • THE SCIENCE OF DRUG THERAPY
  • NEUROTRANSMISSION: THE AUTONOMIC AND SOMATIC MOTOR NERVOUS SYSTEMS
  • MUSCARINIC RECEPTOR AGONISTS AND ANTAGONISTS
  • ANTICHOLINESTERASE AGENTS
  • AGENTS ACTING AT THE NEUROMUSCULAR JUNCTION AND AUTONOMIC GANGLIA
  • ADRENERGIC AGONISTS AND ANTAGONISTS
  • 5-HYDROXYTRYPTAMINE (SEROTONIN): RECEPTOR AGONISTS AND ANTAGONISTS
  • NEUROTRANSMISSION AND THE CENTRAL NERVOUS SYSTEM
  • GENERAL ANESTHETICS
  • LOCAL ANESTHETICS
  • THERAPEUTIC GASES: OXYGEN, CARBON DIOXIDE, NITRIC OXIDE, AND HELIUM
  • HYPNOTICS AND SEDATIVES
  • DRUG THERAPY OF DEPRESSION AND ANXIETY DISORDERS
  • PHARMACOTHERAPY OF PSYCHOSIS AND MANIA
  • PHARMACOTHERAPY OF THE EPILEPSIES
  • TREATMENT OF CENTRAL NERVOUS SYSTEM DEGENERATIVE DISORDERS
  • OPIOID ANALGESICS
  • ETHANOL
  • DRUG ADDICTION AND DRUG ABUSE
  • HISTAMINE, BRADYKININ, AND THEIR ANTAGONISTS
  • LIPID-DERIVED AUTACOIDS: EICOSANOIDS AND PLATELET-ACTIVATING FACTOR
  • ANALGESIC-ANTIPYRETIC AGENTS; PHARMACOTHERAPY OF GOUT
  • PHARMACOTHERAPY OF ASTHMA
  • DIURETICS
  • VASOPRESSIN AND OTHER AGENTS AFFECTING THE RENAL CONSERVATION OF WATER
  • RENIN AND ANGIOTENSIN
  • TREATMENT OF MYOCARDIAL ISCHEMIA
  • THERAPY OF HYPERTENSION
  • PHARMACOTHERAPY OF CONGESTIVE HEART FAILURE
  • ANTIARRHYTHMIC DRUGS
  • DRUG THERAPY FOR HYPERCHOLESTEROLEMIA AND DYSLIPIDEMIA
  • PHARMACOTHERAPY OF GASTRIC ACIDITY, PEPTIC ULCERS, AND GASTROESOPHAGEAL REFLUX DISEASE
  • TREATMENT OF DISORDERS OF BOWEL MOTILITY AND WATER FLUX; ANTIEMETICS; AGENTS USED IN BILIARY AND PANCREATIC DISEASE
  • PHARMACOTHERAPY OF INFLAMMATORY BOWEL DISEASE
  • CHEMOTHERAPY OF PROTOZOAL INFECTIONS: MALARIA
  • CHEMOTHERAPY OF PROTOZOAL INFECTIONS: AMEBIASIS, GIARDIASIS, TRICHOMONIASIS, TRYPANOSOMIASIS, LEISHMANIASIS, AND OTHER PROTOZOAL INFECTIONS
  • CHEMOTHERAPY OF HELMINTH INFECTIONS
  • GENERAL PRINCIPLES OF ANTIMICROBIAL THERAPY
  • SULFONAMIDES, TRIMETHOPRIM-SULFAMETHOXAZOLE, QUINOLONES, AND AGENTS FOR URINARY TRACT INFECTIONS
  • PENICILLINS, CEPHALOSPORINS, AND OTHER b-LACTAM ANTIBIOTICS
  • AMINOGLYCOSIDES
  • PROTEIN SYNTHESIS INHIBITORS AND MISCELLANEOUS ANTIBACTERIAL AGENTS
  • CHEMOTHERAPY OF TUBERCULOSIS, MYCOBACTERIUM AVIUM COMPLEX DISEASE, AND LEPROSY
  • ANTIMICROBIAL AGENTS: ANTIFUNGAL AGENTS
  • ANTIVIRAL AGENTS (NONRETROVIRAL)
  • ANTIRETROVIRAL AGENTS AND TREATMENT OF HIV INFECTION
  • ANTINEOPLASTIC AGENTS
  • IMMUNOSUPPRESSANTS, TOLEROGENS, AND IMMUNOSTIMULANTS
  • HEMATOPOIETIC AGENTS: GROWTH FACTORS, MINERALS, AND VITAMINS
  • BLOOD COAGULATION AND ANTICOAGULANT, THROMBOLYTIC, AND ANTIPLATELET DRUGS
  • PITUITARY HORMONES AND THEIR HYPOTHALAMIC RELEASING HORMONES
  • THYROID AND ANTITHYROID DRUGS
  • ESTROGENS AND PROGESTINS
  • ANDROGENS
  • ADRENOCORTICOTROPIC HORMONE; ADRENOCORTICAL STEROIDS AND THEIR SYNTHETIC ANALOGS; INHIBITORS OF THE SYNTHESIS AND ACTIONS OF ADRENOCORTICAL HORMONES
  • INSULIN, ORAL HYPOGLYCEMIC AGENTS, AND THE PHARMACOLOGY OF THE ENDOCRINE PANCREAS
  • AGENTS AFFECTING MINERAL ION HOMEOSTASIS AND BONE TURNOVER
  • DERMATOLOGICAL PHARMACOLOGY
  • OCULAR PHARMACOLOGY
  • PRINCIPLES OF TOXICOLOGY AND TREATMENT OF POISONIN
  • HEAVY METALS AND HEAVY-METAL ANTAGONISTS

Back to Pharmacology Home Page